‘More babies at risk of serious illness next winter due to underfunding of Pharmac’
More children are at risk of serious infection from RSV following a decision to cut funding for a medicine that prevents serious infection, reduces hospitalisations and can save lives. The Asthma and Respiratory Foundation NZ is supporting calls from paediatricians urging Pharmac to reconsider its decision to stop funding Palivizumab – a monoclonal antibody injection ...